Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses
Sign Up to like & getrecommendations! Published in 2017 at "Cell"
DOI: 10.1016/j.cell.2017.04.037
Abstract: Experimental monoclonal antibody (mAb) therapies have shown promise for treatment of lethal Ebola virus (EBOV) infections, but their species-specific recognition of the viral glycoprotein (GP) has limited their use against other divergent ebolaviruses associated with… read more here.
Keywords: sites vulnerability; human survivor; vulnerability broad; antibodies human ... See more keywords